Oral Senescence: From Molecular Biology to Clinical Research
Open Access
- 1 April 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Dental Medicine
- Vol. 3
Abstract
Cellular senescence is an irreversible cell cycle arrest occurring following multiple rounds of cell division (replicative senescence) or in response to cellular stresses such as ionizing radiation, signaling imbalances and oxidative damage (stress-induced premature senescence). Even very small numbers of senescent cells can be deleterious and there is evidence that senescent cells are instrumental in a number of oral pathologies including cancer, oral sub mucous fibrosis and the side effects of cancer therapy. In addition, senescent cells are present and possibly important in periodontal disease and other chronic inflammatory conditions of the oral cavity. However, senescence is a double-edged sword because although it operates as a suppressor of malignancy in pre-malignant epithelia, senescent cells in the neoplastic environment promote tumor growth and progression. Many of the effects of senescent cells are dependent on the secretion of an array of diverse therapeutically targetable proteins known as the senescence-associated secretory phenotype. However, as senescence may have beneficial roles in wound repair, preventing fibrosis and stem cell activation the clinical exploitation of senescent cells is not straightforward. Here, we discuss biological mechanisms of senescence and we review the current approaches to target senescent cells therapeutically, including senostatics and senolytics which are entering clinical trials.Keywords
This publication has 105 references indexed in Scilit:
- Metabolomic markers reveal novel pathways of ageing and early development in human populationsInternational Journal of Epidemiology, 2013
- Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancerEMBO Molecular Medicine, 2012
- Oncogene‐induced telomere dysfunction enforces cellular senescence in human cancer precursor lesionsThe EMBO Journal, 2012
- Deletion of the Mammalian INDY Homolog Mimics Aspects of Dietary Restriction and Protects against Adiposity and Insulin Resistance in MiceCell Metabolism, 2011
- Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote TumorigenesisMolecular Cell, 2011
- p38MAPK is a novel DNA damage response‐independent regulator of the senescence‐associated secretory phenotypeThe EMBO Journal, 2011
- The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healingNature Cell Biology, 2010
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Three clonal types of keratinocyte with different capacities for multiplication.Proceedings of the National Academy of Sciences, 1987